GNH USA

Europe — EMA

Mononitrato De Isossorbido Mylan (Isosorbide Mononitrate)

GNH USA supplies Mononitrato De Isossorbido Mylan (Isosorbide mononitrate), a nitrate for angina pectoris and chronic heart failure.

Request sourcing

1
Pack/s

What is Isosorbide Mononitrate?

Isosorbide mononitrate, the active ingredient in Mononitrato De Isossorbido Mylan, is a nitrate presented as an oral tablet for oral use. It is used for prophylaxis and treatment of angina pectoris and for management of chronic heart failure in adults.

GNH USA supplies Mononitrato De Isossorbido Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Isosorbide Mononitrate used for?

Isosorbide mononitrate is an anti‑anginal nitrate that reduces myocardial oxygen demand and improves cardiac output.

- Angina pectoris: decreases the frequency and severity of chest pain episodes. - Chronic heart failure: enhances exercise tolerance and reduces symptoms of fluid overload. - Stable coronary artery disease: helps prevent ischemic episodes during daily activities.

What are the side effects of Isosorbide Mononitrate?

Isosorbide mononitrate may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Headache: mild to moderate, often transient. - Dizziness or light‑headedness, especially on standing. - Flushing: warmth and redness of the skin. - Nausea or abdominal discomfort. - Palpitations: sensation of rapid or irregular heartbeat.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Syncope: fainting episodes due to sudden blood pressure fall. - Methemoglobinemia: rare disorder affecting oxygen transport. - Allergic reactions: rash, itching, or swelling of the face and throat.

What precautions apply to Isosorbide Mononitrate?

Before initiating therapy, clinicians should evaluate patient history and comorbid conditions.

- Cardiovascular status: assess for hypotension or recent myocardial infarction. - Concomitant nitrate use: avoid combined therapy to prevent severe hypotension. - Phosphodiesterase‑5 inhibitors: do not co‑administer with drugs such as sildenafil. - Renal or hepatic impairment: adjust monitoring as clearance may be altered. - Pregnancy and lactation: use only if potential benefit justifies potential risk. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

What does Isosorbide Mononitrate interact with?

Isosorbide mononitrate interacts with several drug classes that influence vascular tone or nitric‑oxide pathways.

Major Interactions (Avoid): - Other nitrates or nitroglycerin: additive vasodilatory effect leading to profound hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): risk of severe blood pressure drop.

Moderate Interactions (Monitor Closely): - Antihypertensives (ACE inhibitors, beta‑blockers, diuretics): may enhance blood pressure‑lowering effect. - Alcohol: can increase dizziness and hypotensive episodes. - Certain antacids (aluminum‑containing): may affect absorption if taken simultaneously.

Frequently asked questions

What conditions is Mononitrato De Isossorbido Mylan used for?+
Mononitrato De Isossorbido Mylan, containing isosorbide mononitrate, is prescribed to prevent and treat episodes of angina pectoris and to manage symptoms of chronic heart failure in adult patients. It works by reducing the heart’s workload and improving blood flow to the myocardium.
How does isosorbide mononitrate work in the body?+
Isosorbide mononitrate is converted to nitric oxide after oral absorption. Nitric oxide activates guanylate cyclase, raising cyclic GMP levels in vascular smooth muscle. This cascade leads to relaxation of arteries and veins, lowering preload and afterload, which decreases myocardial oxygen demand and relieves ischemic chest pain.
What is the usual dose of Mononitrato De Isossorbido Mylan?+
The appropriate dose is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and tolerance. Dosage regimens may vary, and patients should follow the exact instructions provided by their healthcare professional.
Is Mononitrato De Isossorbido Mylan safe during pregnancy or breastfeeding?+
Safety data for isosorbide mononitrate in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant. Pregnant or nursing patients must discuss treatment options with their physician.
How do I order Mononitrato De Isossorbido Mylan from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Mononitrato De Isossorbido Mylan compare with other anti‑anginal drugs?+
Compared with short‑acting nitrates such as nitroglycerin, isosorbide mononitrate offers a longer duration of action and more stable plasma levels, allowing once‑daily dosing. Unlike beta‑blockers, it directly reduces preload and afterload without affecting heart rate, making it suitable for patients who cannot tolerate beta‑blockade.
What are the recommended storage conditions for Mononitrato De Isossorbido Mylan?+
Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original packaging to protect from moisture and direct sunlight. Do not refrigerate or freeze the product, as temperature extremes can affect tablet integrity.
How is Mononitrato De Isossorbido Mylan administered?+
The medication is taken orally, usually with a glass of water. It can be taken with or without food, but patients should avoid crushing or chewing the tablets unless specifically instructed by a healthcare professional.
What are the most serious risks associated with Mononitrato De Isossorbido Mylan?+
Serious adverse events include severe hypotension, syncope, and rare cases of methemoglobinemia. Patients should be educated to recognize symptoms such as dizziness, fainting, or unusual shortness of breath and seek immediate medical attention if they occur.
Who should not use Mononitrato De Isossorbido Mylan?+
The drug is contraindicated in patients with known hypersensitivity to isosorbide mononitrate or any nitrate, those who have taken phosphodiesterase‑5 inhibitors within 24 hours, and individuals with severe anemia or closed‑angle glaucoma. Clinicians should review medical history before prescribing.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Isosorbide Mononitrate
Route
Oral Use
Manufacturer
Viatris Limited
Origin
EU

Related products